このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

ESPB Versus Combined PIPB and RIB for Analgesia in Minimally Invasive Cardiac Surgery

2026年11月9日 更新者:Ankara Etlik City Hospital

Comparison of the Postoperative Analgesic Efficacy of Combined Parasternal Intercostal Plane and Rhomboid Intercostal Blocks Versus Erector Spinae Plane Block in Minimally Invasive Cardiac Surgery: A Prospective Randomized Controlled Trial

Pain after minimally invasive cardiac surgery can affect breathing, movement, and recovery. Regional anesthesia techniques may help reduce postoperative pain and the need for opioid pain medications.

This study aims to compare two ultrasound-guided regional anesthesia approaches for pain management after minimally invasive cardiac surgery: erector spinae plane block (ESPB) and a combination of parasternal intercostal plane block (PIPB) and rhomboid intercostal block (RIB).

A total of 56 adult patients undergoing minimally invasive cardiac surgery will be randomly assigned to one of two groups. One group will receive ESPB, while the other group will receive the combined PIPB and RIB technique. Both approaches will use the same total dose of local anesthetic and will be performed after induction of general anesthesia and before surgery.

The main objective is to compare how pain scores at rest change between the two groups during the first 12 hours after removal of the breathing tube. Pain will be assessed using a numerical scale from 0 (no pain) to 10 (worst imaginable pain).

The study will also evaluate postoperative opioid consumption, additional pain measurements, quality of recovery, and block-related adverse events. Quality of recovery will be assessed using the QoR-15T questionnaire before surgery and 48 hours after extubation.Patient-reported acceptability of postoperative pain management will also be evaluated using a Likert scale at 48 hours postoperatively.

The findings may help identify effective regional anesthesia strategies for postoperative pain management in minimally invasive cardiac surgery.

調査の概要

状態

まだ募集していません

条件

介入・治療

詳細な説明

Postoperative pain management is an important component of enhanced recovery after minimally invasive cardiac surgery (MICS). Although minimally invasive approaches avoid conventional median sternotomy, patients may experience substantial pain related to the thoracic incision, intercostal tissue injury, and chest drains.

Ultrasound-guided regional anesthesia techniques are increasingly used as part of multimodal analgesia in cardiac surgery. The erector spinae plane block (ESPB) is a fascial plane block that may provide analgesia through the spread of local anesthetic across multiple thoracic segments. The combined parasternal intercostal plane block (PIPB) and rhomboid intercostal block (RIB) approach targets different regions of the thoracic wall and may provide complementary analgesic coverage.

This prospective, single-center, randomized controlled trial will compare the postoperative analgesic efficacy of unilateral ESPB with combined PIPB and RIB in 56 adult patients undergoing minimally invasive cardiac surgery.

Following induction of general anesthesia and before surgical incision, patients will receive one of two ultrasound-guided regional anesthesia approaches. The ESPB group will receive 30 mL of 0.25% bupivacaine on the surgical side. The combined-block group will receive 15 mL of 0.25% bupivacaine for PIPB and 15 mL of 0.25% bupivacaine for RIB. The total local anesthetic dose will be identical between groups.

All patients will receive standardized perioperative care and multimodal postoperative analgesia, including acetaminophen and patient-controlled tramadol analgesia.

The primary outcome will be the between-group difference in the trajectory of resting Numeric Rating Scale (NRS) pain scores at 0, 2, 4, 8, and 12 hours after extubation, evaluated through the group-by-time interaction.

Secondary outcomes will include postoperative pain measurements at additional time points, cumulative tramadol consumption during the first 24 hours, time to first rescue analgesia, postoperative quality of recovery assessed using the Turkish version of the Quality of Recovery-15 questionnaire (QoR-15T),Patient-reported acceptability of postoperative pain management will also be assessed using a Likert scale at 48 hours postoperatively and block-related adverse events.

The study aims to determine whether the combined PIPB and RIB approach offers a clinically useful alternative to ESPB for postoperative analgesia after minimally invasive cardiac surgery.

研究の種類

介入

入学 (推定)

56

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

  • 名前:Havva SAYHAN KAPLAN
  • 電話番号:+905056621021
  • メール:hsayhan@gmail.com

研究場所

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年~80年 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

  • Patients aged 18-80 years.
  • Patients scheduled for elective minimally invasive cardiac surgery (MICS).
  • American Society of Anesthesiologists (ASA) physical status I-III.
  • Body mass index (BMI) between 18 and 35 kg/m².
  • Ability to communicate adequately in Turkish and participate in postoperative pain assessments.
  • Provision of written informed consent.

Exclusion Criteria:

  • Age younger than 18 years or older than 80 years.
  • ASA physical status IV.
  • BMI below 18 or above 35 kg/m².
  • Severe hepatic or renal dysfunction.
  • Pregnancy or breastfeeding.
  • Dementia, psychiatric disorders, or cognitive impairment preventing reliable cooperation or pain assessment.
  • Language barriers preventing effective communication.
  • History of alcohol, substance, or medication dependence.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:ダブル

武器と介入

参加者グループ / アーム
介入・治療
アクティブコンパレータ:Erector Spinae Plane Block (ESPB) group

Patients allocated to this group will receive a unilateral ultrasound-guided erector spinae plane block (ESPB) at the T5 vertebral level on the surgical side after induction of general anesthesia and before surgical incision. A total of 30 mL of 0.25% bupivacaine (75 mg) will be administered.

An ultrasound-guided unilateral erector spinae plane block (ESPB) will be performed at the T5 vertebral level on the surgical side after induction of general anesthesia and before surgical incision. A total of 30 mL of 0.25% bupivacaine (75 mg) will be injected into the fascial plane between the erector spinae muscle and the transverse process.

実験的:Combined Parasternal Intercostal Plane Block and Rhomboid Intercostal Block

Patients allocated to this group will receive a combination of ultrasound-guided parasternal intercostal plane block (PIPB) and rhomboid intercostal block (RIB) after induction of general anesthesia and before surgical incision. A total of 15 mL of 0.25% bupivacaine will be administered for PIPB and 15 mL of 0.25% bupivacaine for RIB on the surgical side. The total local anesthetic volume will be 30 mL (75 mg).

Following induction of general anesthesia and before surgical incision, patients will receive two ultrasound-guided fascial plane blocks on the surgical side. A parasternal intercostal plane block (PIPB) will be performed with 15 mL of 0.25% bupivacaine, followed by a rhomboid intercostal block (RIB) with 15 mL of 0.25% bupivacaine injected between the rhomboid major and intercostal muscles. The total administered volume will be 30 mL of 0.25% bupivacaine (75 mg).

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Postoperative Resting Pain Scores Assessed by the Numeric Rating Scale (NRS)
時間枠:At 0, 2, 4, 8, and 12 hours after extubation

Postoperative pain intensity at rest will be assessed using the Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain). Measurements will be obtained at 0, 2, 4, 8, and 12 hours after extubation. The primary outcome will be the group-by-time interaction in resting NRS scores, comparing the erector spinae plane block (ESPB) group with the combined parasternal intercostal plane block and rhomboid intercostal block (PIPB + RIB) group using a repeated-measures statistical approach.

At 0, 2, 4, 8, and 12 hours after extubation

二次結果の測定

結果測定
メジャーの説明
時間枠
Cumulative Postoperative Tramadol Consumption Within 24 Hours
時間枠:From extubation to 24 hours after extubation

Total tramadol consumption (mg) during the first 24 hours after extubation will be recorded. Postoperative patient-controlled analgesia (PCA) will be provided using tramadol with a 10 mg bolus dose, a 10-minute lockout interval, and no basal infusion. Cumulative tramadol consumption will be compared between the ESPB and combined PIPB + RIB groups. Higher consumption indicates greater postoperative opioid requirements.

From extubation to 24 hours after extubation
Postoperative Pain Score at Rest at 24 Hours
時間枠:24 hours after extubation

Postoperative pain intensity at rest will be assessed using the Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain). Pain scores will be recorded at 24 hours after extubation and compared between the ESPB and combined PIPB + RIB groups. Higher scores indicate greater pain intensity.

24 hours after extubation
Change in Quality of Recovery-15 Turkish Version (QoR-15T) Score
時間枠:Preoperatively (baseline) and 48 hours after extubation

Quality of postoperative recovery will be assessed using the validated Turkish version of the 15-item Quality of Recovery questionnaire (QoR-15T). The questionnaire evaluates five domains: pain, physical comfort, physical independence, psychological support, and emotional state. Each item is scored from 0 to 10, yielding a total score ranging from 0 to 150, with higher scores indicating better recovery quality. The QoR-15T will be administered preoperatively and at 48 hours after extubation. The change in total score from baseline to 48 hours will be compared between the ESPB and combined PIPB + RIB groups.

Preoperatively (baseline) and 48 hours after extubation
Patient-Reported Acceptability of Postoperative Pain Management at 48 Hours
時間枠:48 hours after extubation

Patient-reported acceptability of postoperative pain management will be assessed using a five-point Likert scale at 48 hours after extubation. Patients will rate their agreement with the statement, "The level of pain I experienced after surgery was acceptable to me." Responses will be scored as follows: 1 = Strongly disagree, 2 = Disagree, 3 = Neither agree nor disagree, 4 = Agree, and 5 = Strongly agree. Higher scores indicate greater acceptability of postoperative pain management. The distribution of responses will be compared between the ESPB and combined PIPB + RIB groups.

48 hours after extubation
Time to First Rescue Analgesia
時間枠:Within 24 hours after extubation

Time elapsed from extubation to the first administration of rescue analgesia, measured in minutes.

Within 24 hours after extubation
Incidence of Block-related Adverse Events
時間枠:Within 24 hours after block administration

Number of participants experiencing block-related adverse events, including pneumothorax and local anesthetic systemic toxicity.

Within 24 hours after block administration
Postoperative Pain Score During Movement at 24 Hours
時間枠:24 hours after extubation

Postoperative pain intensity during movement will be assessed using the Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain). Pain scores will be recorded at 24 hours after extubation and compared between the ESPB and combined PIPB + RIB groups. Higher scores indicate greater pain intensity.

24 hours after extubation

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • 主任研究者:havva sayhan kaplan, MD、Ankara Etlik City Hospital

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年12月1日

一次修了 (推定)

2027年3月1日

研究の完了 (推定)

2027年3月1日

試験登録日

最初に提出

2026年11月9日

QC基準を満たした最初の提出物

2026年11月9日

最初の投稿 (実際)

2026年11月13日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月13日

QC基準を満たした最後の更新が送信されました

2026年11月9日

最終確認日

2026年11月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • MICS-ESPB-PIPRIB-2026

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。